Clinical Genitourinary Cancer
Publisher: Elsevier · ISSN 1558-7673 · 78 articles
- The Effect of Socioeconomic Inequality as Measured by a Standardized Neighborhood Deprivation Index on the Tumor Microenvironment and Genomics of Bladder Cancer
- Log Odds of Positive Lymph Nodes as a Novel Prognostic Predictor for Bladder Cancer: A Systematic Review and Meta-Analysis
- DV-Based Kidney-Sparing Therapy for High-Risk Upper Tract Urothelial Carcinoma: An Exploratory Single-Center Real-World Study
- Growth-Differentiation-Factor 15 (GDF15) and Hepcidin as Prognostic Biomarkers for Abiraterone-Treated Metastatic Castration-Resistant Prostate Cancer
- The 4-cm Rule in Partial Nephrectomy: Analysis of Surgical Selection and Safety Using Japan’s National Clinical Database
- Prognostic Value of Preoperative Fibrinogen in Metastatic Clear Cell Renal Cell Carcinoma Patients Undergoing Cytoreductive Nephrectomy
- Pre-therapeutic PSMA PET Imaging Biomarkers Demonstrate Prognostic Value in Patients Undergoing [177Lu]Lu-PSMA Therapy: A Systematic Review and Meta-analysis
- Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review
- Prognostic Value of Double-expressor Phenotype and an Exploratory DEP-IPI Risk Model in Primary Testicular Diffuse Large B-cell Lymphoma: A Multicenter Retrospective Cohort Study
- Age at Diagnosis and Postoperative Outcomes Among Men Treated for Prostate Cancer in the U.S. Military Health System
- Tumor Mutational Burden Predicts the Outcome of Patients With Muscle-invasive bladder Cancer Undergoing Immune-checkpoint Inhibitor-Based Neoadjuvant Therapy
- Nomograms for Predicting Recurrence and Oncologic Outcomes After Partial Nephrectomy for Renal Cell Carcinoma
- Relationship between Socioeconomic Health Factors and Urothelial Carcinoma of the Bladder amongst an Insured population
- Definitive Chemoradiotherapy Versus Radical Cystectomy for Small Cell Carcinoma of the Bladder: A Multicenter Retrospective Study
- Detection of FGFR Alterations in Urothelial Carcinoma: Current Diagnostic Methodologies, Technical Considerations and Future Perspectives
- Why Has Prostate Cancer Research Lagged Behind? Advocacy, Biology, and the Road Ahead
- Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma
- Risk Factors and Treatment Outcomes in Metastatic Prostate Cancer With Brain Metastases
- Sex-Specific Differences in Disease-Free, Progression-Free and Overall Survival Following Enfortumab Vedotin Therapy for Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis
- Quality-of-Life in CRPC Patients Treated With Enzalutamide Versus Abiraterone: Impact of Standard and Modified Dosing
- Association Between Enfortumab Vedotin-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
- Treatment Type and Mortality for Black Versus White Patients With Muscle-Invasive Bladder Cancer
- The Contemporary Pattern of Radical Cystectomy in the Treatment of High-Grade Non-Muscle Invasive Bladder Cancer
- PARP Inhibitor Plus Androgen-receptor Signaling Inhibitor Versus the Same Inhibitor Alone in Homologous-Recombination-Repair-Altered Metastatic Prostate Cancer Across the Hormone-Sensitive and Castration-Resistant Continuum: A Systematic Review and Meta-Analysis
- GLP-1RAs Use and Postoperative Outcomes in T2DM Patients Undergoing Radical Nephrectomy
- Clinical Outcomes of Metastatic Urothelial Carcinoma Patients Discontinuing Enfortumab Vedotin Due to Toxicity and/or Clinical Response
- Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report
- Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence
- De-Escalation Therapy in Metastatic Prostate Cancer: A Retrospective Study on Intermittent ADT and ARPI Combination Treatment
- Patterns of Poly(ADP-Ribose) Polymerase Inhibitor Use and Overall Survival in United States Veterans With Prostate Cancer